rofecoxib has been researched along with HIV Coinfection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johansson, CC | 1 |
| Bryn, T | 1 |
| Aandahl, EM | 1 |
| Areklett, MA | 1 |
| Aukrust, P | 1 |
| Taskén, K | 1 |
| Frøland, SS | 1 |
1 trial available for rofecoxib and HIV Coinfection
| Article | Year |
|---|---|
Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cell Division; Cyclooxygenase Inhibitors; Female; HIV | 2004 |